Expression of DNA repair and metabolic genes in response to a flavonoid-rich diet

British Journal of Nutrition

Volumn 98, Issue 3, 2007, Pages 525-533

  Guarrera, Simonetta ^a   Sacerdote, Carlotta ^b   Fiorini, Laura ^b   Marsala, Rosa ^b   Polidoro, Silvia ^a   Gamberini, Sara ^a,b   Saletta, Federica ^a   Malaveille, Christian ^c   Talaska, Glenn ^d   Vineis, Paolo ^a,e   Matullo, Giuseppe ^a,b  

^a ISI FOUNDATION   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^d UNIVERSITY OF CINCINNATI   (United States)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Dietary intervention trial; DNA repair; Flavonoids; Gene expression

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 4; FLAVONOID; GENE PRODUCT; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; POLYPHENOL; PROTEIN APEX; PROTEIN OGG1; PROTEIN XPA; PROTEIN XRCC1; PROTEIN XRCC3; REACTIVE OXYGEN METABOLITE; TOBACCO SMOKE; UNCLASSIFIED DRUG; XERODERMA PIGMENTOSUM GROUP C PROTEIN; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ADULT; AGED; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DNA REPAIR; FOOD INTAKE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN; RANDOMIZED CONTROLLED TRIAL; SMOKING; UPREGULATION; URINALYSIS;

ADULT; ANTIOXIDANTS; DIET; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; EATING; FLAVONOIDS; FOOD ANALYSIS; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MUTAGENICITY TESTS; PHENOLS; SMOKING; UP-REGULATION;

NICOTIANA TABACUM;

EID: 34547963298     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114507725151     Document Type: Article

References (73)

1. Kris-Etherton PM, Hecker KD, Bonanome A, Coval SM, Binkoski AE, Hilpert KF, Griel AE & Etherton TD (2002) Bioactive compounds in foods: Their role in the prevention of cardiovascular disease and cancer. Am J Med 113, Suppl 9B, 71S-88S.
2. Lock K, Pomerleau J, Causer L, Altmann DR & McKee M (2005) The global burden of disease attributable to low consumption of fruit and vegetables: Implications for the global strategy on diet. Bull World Health Organ 83, 100-108.
3. Danaei G, Vander Hoorn S, Lopez AD, Murray CJ, Ezzati M & Comparative Risk Assessment collaborating group (Cancers) (2005) Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784-1793.
4. He FJ, Nowson CA & MacGregor GA (2006) Fruit and vegetable consumption and stroke: Meta-analysis of cohort studies. Lancet 367, 320-326.
5. Pomerleau J, Lock K & McKee M (2006) The burden of cardiovascular disease and cancer attributable to low fruit and vegetable intake in the European Union: Differences between old and new Member States. Public Health Nutr 9, 575-583.
6. Dragsted LO, Strube M & Larsen JC (1993) Cancer-protective factors in fruits and vegetables: Biochemical and biological background. Pharmacol Toxicol 72, 116-135.
7. Formica JV & Regelson W (1995) Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 33, 1061-1080.
8. Waladkhani AR & Clemens MR (1998) Effect of dietary phytochemicals on cancer development. Int J Mol Med 1, 747-753.
9. Bub A, Watzl B, Blockhaus M, Briviba K, Liegibel U, Muller H, Pool-Zobel BL & Rechkemmer G (2003) Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J Nutr Biochem 14, 90-98.
10. Hakim IA, Harris RB, Brown S, Chow HH, Wiseman S, Agarwal S & Talbot W (2003) Effects of increased tea consumption on oxidative DNA damage among smokers: A randomized controlled study. J Nutr 133, 3303S-3309S.
11. Karou D, Dicko MH, Simpore J & Traore AS (2005) Antioxidant and antibacterial activities of polyphenols from ethnomedicinal plants of Burkina Faso. Afr J Biotechnol 4, 823-828.
12. Collins AR, Harrington V, Drew J & Melvin R (2003) Nutritional modulation of DNA repair in a human intervention study. Carcinogenesis 24, 511-515.
13. Moller P, Vogel U, Pedersen A, Dragsted LO, Sandstrom B & Loft S (2003) No effect of 600 grams fruit and vegetables per day on oxidative DNA damage and repair in healthy nonsmokers. Cancer Epidemiol Biomarkers Prev 12, 1016-1022.
14. Janssen PLTMK, Mensik RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC & Katan MB (1998) Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: Results from an in vitro and a dietary supplement study. Am J Clin Nutr 67, 255-262.
15. Ross JA & Kasum CM (2002) Dietary flavonoids: Bioavailability, metabolic effects, and safety. Ann Rev Nutr 22, 19-34.
16. Weisburger JH & Chung FL (2002) Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem Toxicol 40, 1145-1154.
17. Ren W, Qiao Z, Wang H, Zhu L & Zhang L (2003) Flavonoids: Promising anticancer agents. Med Res Rev 23, 519-534.
18. Knekt P, Jarvinen R, Seppanen R, Hellovaara M, Teppo L, Pukkala E & Aromaa A (1997) Dietary flavonoids and the risk of lung cancer and other malignant neoplasms. Am J Epidemiol 146, 223-230.
19. Hirvonen T, Virtamo J, Korhonen P, Albanes D & Pietinen P (2001) Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control 12, 789-796.
20. Ciolino HP & Yeh GC (1999) Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol. Mol Pharmacol 56, 760-767.
21. Chao PDL, Hsiu SL & Hou YC (2002) Flavonoids in herbs: Biological fates and potential interactions with xenobiotics. J Food Drug Anal 10, 219-228.
22. Murray M (2006) Altered CYP expression and function in response to dietary factors: Potential roles in disease pathogenesis. Curr Drug Metab 7, 67-81.
23. Moon YJ, Wang X & Morris ME (2006) Dietary flavonoids: Effects on xenobiotic and carcinogen metabolism. Toxicol in Vitro 20, 187-210.
24. Ciolino HP, Daschner PJ & Yeh GC (1999) Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem J 340, 715-722.
25. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Human Cancer (1986) Tobacco Smoking, vol 38. Lyon: IARC Scientific Publications.
26. Zeegers MP, Kellen E, Buntinx F & van den Brandt PA (2004) The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review. World J Urol 21, 392-401.
27. Schollnberger H, Manuguerra M, Bijwaard H, Boshuizen H, Altenburg HP, Rispens SM, Brugmans MJ & Vineis P (2006) Analysis of epidemiological cohort data on smoking effects and lung cancer with a multistage cancer model. Carcinogenesis 27, 1432-1444.
28. Nair J, Ohshima H, Nair UJ & Bartsch H (1996) Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users. Crit Rev Toxicol 26, 149-161.
29. Phillips DH (2002) Smoking-related DNA and protein adducts in human tissues. Carcinogenesis 23, 1979-2004.
30. Godschalk R, Nair J, van Schooten FJ, Risch A, Drings P, Kayser K, Dienemann H & Bartsch H (2002) Comparison of multiple DNA adduct types in tumor adjacent human lung tissue: Effect of cigarette smoking. Carcinogenesis 23, 2081-2086.
31. Malaveille C, Hautefeuille A, Pignatelli B, Talaska. G, Vineis P & Bartsch H (1998) Antimutagenic dietary phenolics as antigenotoxic substances in urothelium of smokers. Mutat Res 402, 219-224.
32. Malaveille C, Fiorini L, Bianchini M, Davico L, Bertinetti S, Allegro G, Hautefeuille A, Sacerdote C & Vineis P (2004) Randomized controlled trial of dietary intervention: Association between level of urinary phenolics and anti-mutagenicity. Mutat Res 561, 83-90.
33. Strick R, Strissel PL, Borgers S, Smith SL & Rowley JD (2000) Dietary bioflavonoids induce cleavage in the MML gene and may contribute to infant leukemia. PNAS 97, 4790-4795.
34. Brevik A, Rasmussen SE, Drevon CA & Andersen LF (2004) Urinary excretion of flavonoids reflects even small changes in the dietary intake of fruits and vegetables. Cancer Epidemiol Biomarkers Prev 13, 843-849.
35. Malaveille C, Hautefeuille A, Pignatelli B, Talaska G, Vineis P & Bartsch H (1996) Dietary phenolics as anti-mutagens and inhibitors of tobacco-related DNA adduction in the urothelium of smokers. Carcinogenesis 17, 2193-2200.
36. Talaska G, Schamer M, Skipper P, Tannenbaum S, Caporaso N, Unruh L, Kadlubar FF, Bartsch H, Malaveille C & Vineis P (1991) Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: Association with smoking, hemoglobin adducts, and urinary mutagenicity. Cancer Epidemiol Biomarkers Prev 1, 61-66.
37. Applied Biosystems (2001) ABI prism 7700 SDS User Bulletin #2. Foster City, CA: Applied Biosystems.
38. de Vries JHM, Hollman PCH, Meyboom S, Buysman MN, Zock PL, van Staveren WA & Katan MB (1998) Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr 68, 60-65.
39. Bourne LC & Rice-Evance C (1999) Detecting and measuring bioavailability of phenolic and flavonoids in humans: Pharmacokinetics of urinary excretion of dietary ferulic acid. Methods Enzymol 299, 91-106.
40. Yang CS, Landau JM, Huang MT & Newmark HL (2001) Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr 21, 381-406.
41. Tebbs RS, Zhao Y, Tucker JD, Scheerer JB, Siciliano MJ, Hwang M, Liu N, Legerski RJ & Thompson LH (1995) Correction of chromosomal instability and sensitivity to diverse mutagens by a cloned cDNA of the XRCC3 DNA repair gene. Proc Natl Acad Sci USA 92, 6354-6358.
42. Liu N, Lamerdin JE, Tebbs RS, et al. (1998) XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell 1, 783-793.
43. Brenneman MA, Weiss AE, Nickoloff JA & Chen DJ (2000) XRCC3 is required for efficient repair of chromosome breaks by homologous recombination. Mutat Res 459, 89-97.
44. Czerniak B, Li L, Chaturvedi V, Ro JY, Johnston DA, Hodges S & Benedict WF (2000) Genetic modeling of human urinary bladder carcinogenesis. Genes Chromosomes Cancer 27, 392-402.
45. Hartmann A, Rosner U, Schlake G, Dietmaier W, Zaak D, Hofstaedter F & Knuechel R (2000) Clonality and genetic divergence in multifocal low-grade superficial urothelial carcinoma as determined by chromosome 9 and p53 deletion analysis. Lab Invest 80, 709-718.
46. Jang M, Cai L, Udeani GO, et al. (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275, 218-220.
47. Dertinger SD, Silverstone AE & Gasiewicz TA (1998) Influence of aromatic hydrocarbon receptor-mediated events on the genotoxicity of cigarette smoke condensate. Carcinogenesis 19, 2037-2042.
48. Berge G, Øvrebø S, Botnen IV, Hewer A, Phillips DH, Haugen A & Mollerup S (2004) Resveratrol inhibits benzo[a]pyrene-DNA adduct formation in human bronchial epithelial cells. Brit J Cancer 91 333-338.
49. Bukowski JA & Lewis RJ (2000) Hormesis and health: A little of what you fancy may be good for you. South Med J 93, 371-374.
50. Kitchin KT (2002) Defining, explaining and understanding hormesis. Hum Exp Toxicol 21, 105-106, discussion 113-114.
51. Kessler M, Ubeaud G & Jung L (2003) Anti- and pro-oxidant activity of rutin and quercetin derivatives. J Pharm Pharmacol 55, 131-142.
52. Rietjens IM, Boersma MG, van der Woude H, Jeurissen SM, Schutte ME & Alink GM (2005) Flavonoids and alkenylbenzenes: Mechanisms of mutagenic action and carcinogenic risk. Mutat Res 574, 124-138.
53. Degtyar P, Neulander E, Zirkin H, Yusim I, Douvdevani A, Mermershtain W, Kaneti J & Manor E (1997) Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder. Urology 63, 398-401.
54. Dörrenhaus A, Müller JI, Golka Y, Jedrusik P, Schulze H & Föllmann W (2000) Cultures of exfoliated epithelial cells from different locations of the human urinary tract and the renal tubular system. Arch Toxicol 74, 618-626.
55. Fracasso ME, Franceschetti P, Doria D, Talamini G & Bonetti F (2004) DNA breaks as measured by the alkaline comet assay in exfoliated cells as compared to voided urine cytology in the diagnosis of bladder cancer: A study of 105 subjects. Mutat Res 564, 57-64.
56. Murray EB & Edwards JW (2005) Differential induction of micronuclei in peripheral lymphocytes and exfoliated urothelial cells of workers exposed to 4,4′-methylenebis-(2-chloroaniline) (MOCA) and bitumen fumes. Rev Environ Health 20, 163-176.
57. Bollmann M, Heller H, Bankfalvi A, Griefingholt H & Bollmann R (2005) Quantitative molecular urinary cytology by fluorescence in situ hybridization: A tool for tailoring surveillance of patients with superficial bladder cancer? BJU Int 95, 1219-1225.
58. Dörrenhaus A, Muller T & Roos PH (2006) Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch Toxicol (published online 1 September 2006, doi:10.1007/s00204-006-0134-9).
59. 32P-postlabelling: Metabolic phenotype dependence and comparisons with other exposure markers. IARC Sci Publ 124, 331-340.
60. Zhou Q, Talaska G, Jaeger M, et al. (1997) Benzidine-DNA adduct levels in human peripheral white blood cells significantly correlate with levels in exfoliated urothelial cells. Mutat Res 393, 199-205.
61. Talaska G, Maier A, Henn S, Booth-Jones A, Tsuneoka Y, Vermeulen R & Schumann BL (2002) Carcinogen biomonitoring in human exposures and laboratory research: Validation and application to human occupational exposures. Toxicol Lett 134, 39-49.
62. Vermeulen R, Talaska G, Schumann B, Bos RP, Rothman N & Kromhout H (2002) Urothelial cell DNA adducts in rubber workers. Environ Mol Mutagen 39, 306-313.
63. Talaska G, Al-Zoughool M, Malaveille C, et al. (2006) Randomized controlled trial: Effects of diet on DNA damage in heavy smokers. Mutagenesis 21, 179-183.
64. van Acker SA, van den Berg DJ, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJ & Bast A (1996) Structural-aspects of antioxidant activity of flavonoids. Free Radic Biol Med 20, 331-342.
65. Dragsted LO (2003) Antioxidant actions of polyphenols in humans. Int J Vitam Nutr Res 73, 112-119.
66. Sang S, Hou Z, Lambeft JD & Yang CS (2005) Redox properties of tea polyphenols and related biological activities Antioxid Redox Signal 7, 1704-1714.
67. Bartsch H, Pignatelli B, Calmels S & Ohshima H (1993) Inhibition of nitrosation. Basic Life Sci 61, 27-44.
68. Mirvish SS (1995) Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 93, 17-48.
69. Mariappan, Winkler J, Parthiban V, Doss MX, Hescheler J & Sachinidis A (2006) Dietary small molecules and large-scale gene expression studies: an experimental approach for understanding their beneficial effects on the development of malignant and non-malignant proliferative diseases. Curr Med Chem 13, 1481-1489.
70. Lee LT, Huang YT, Hwang JJ, Lee PPH, Ke FC, Nair MP, Kanadaswami C & Lee MT (2002) Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and-apoptosis of pancreatic tumor cells. Anticancer Res 222, 1615-1627.
71. Fresco P, Borges F, Diniz C & Marques MP (2006) New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26 747-766.
72. Narayanan BA (2006) Chemopreventive agents alter global gene expression pattern: Predicting their mode of action and targets. Curr Cancer Drug Targets 6, 711-727.
73. Rahman I, Biswas SK & Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72 1439-1452.